Association between Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios and Coronary Artery Calcification Score among Asymptomatic Patients: Data from a Cross-Sectional Study

Imagem de Miniatura
Arquivos
art_SERRANO JR._Association_between_NeutrophilLymphocyte_and_PlateletLymphocyte_Ratios_and_Coronary_2019.PDF (1.54 MB)
Citações na Scopus
33
Tipo de produção
article
Data de publicação
2019
Editora
HINDAWI LTD
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
LEMOS, James de
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
MEDIATORS OF INFLAMMATION, article ID 6513847, 8p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction. Atherosclerosis is a low-grade inflammatory disease. Among markers of inflammation, importance has been given to the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR). The objective of this study was to examine the association between these hematological indices of inflammation and coronary atherosclerotic calcification in clinically asymptomatic patients. Methods. This study had clinical and laboratorial data collected from consecutive asymptomatic patients that underwent computed tomography coronary artery calcium (CAC) scoring. Risk factors, NLR, and PLR were evaluated at different categories of CAC scoring. Statistical tests included chi-square, linear regression, and logistic regression. Patients (N=247; age 60.4 +/- 8.0 years and 60.7% men) were allocated into four categories according to the CAC score. Results. Respective age, sex (male), NLR, and PLR distribution within groups were as follows: CAC=0 (n=98; 52.5 +/- 13.6 years, 55%, 2.0 +/- 1.0, and 121.5 +/- 41.5), CAC 1-100 (N=64; 61.3 +/- 11.0 years, 60%, 2.2 +/- 1.2, and 125.6 +/- 45.6), CAC 101-400 (N=37; 64.2 +/- 11.6 years, 67%,2.6 +/- 1.3, and 125.4 +/- 55.9), and CAC>400 (N=48; 69.3 +/- 11.1 years, 66%, 3.3 +/- 2.0, and 430.1 +/- 1787.4). The association between risk factors and CAC score was assessed. Hypertension status and smoking status were similar within groups, while the presence of diabetes (P=0.02) and older age (P <= 0.001) was more prevalent in the CAC>400 group. LDL cholesterol was greater in the higher CAC score groups (P=0.002). Multivariate logistic regression of the quartile analysis showed that age and NLR were independently associated with CAC>100 (OR (CI), P value): 2.06 (1.55-2.73, P=0.00001) and 1.82 (1.33-2.49, P=0.0002), respectively. Conclusion. Within asymptomatic patients, NLR provides additional risk stratification, as an independent association between NLR extent and CAD extent was identified. Moreover, PLR was not an inflammation marker for CAD severity.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/31662
Referências
  1. Acanfora D, 2001, AM HEART J, V142, P167, DOI 10.1067/mhj.2001.115792
  2. Afari ME, 2016, EXPERT REV CARDIOVAS, V14, P573, DOI 10.1586/14779072.2016.1154788
  3. Alluri K, 2015, J CARDIOVASC COMPUT, V9, P337, DOI 10.1016/j.jcct.2015.03.015
  4. Angkananard T, 2018, BIOMED RES INT, DOI 10.1155/2018/2703518
  5. Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.009
  6. Balta I, 2014, EXPERT REV CARDIOVAS, V12, P413, DOI 10.1586/14779072.2014.896197
  7. BALTA S, 2002, REVIEW, V14, P885, DOI 10.1080/14779072.2016.1194199
  8. BALTA S, 2002, BALTA, V22, P405, DOI 10.1177/1076029615569568
  9. Balta S, 2016, ANGIOLOGY, V67, P298, DOI 10.1177/0003319715615252
  10. Balta S, 2014, INT J CARDIOL, V176, P267, DOI 10.1016/j.ijcard.2014.06.098
  11. Balta S, 2013, ANGIOLOGY, V64, P627, DOI 10.1177/0003319713480424
  12. Budoff MJ, 2008, VASC HEALTH RISK MAN, V4, P315, DOI 10.2147/VHRM.S1160
  13. CELIK T, 2002, JOURNAL, V18, P720, DOI 10.5603/CJ.2011.0044
  14. Cesar L. A. M., 2014, ARQUIVOS BRASILEIROS, V12, P1
  15. Chaikriangkrai K, 2014, N AM J MED SCI, V6, P433, DOI 10.4103/1947-2714.141625
  16. Cho KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133934
  17. DEMIRKOL S, 2002, BALTA, V20, P250, DOI 10.1177/1076029612467227
  18. Doring Y, 2015, ARTERIOSCL THROM VAS, V35, P288, DOI 10.1161/ATVBAHA.114.303564
  19. dos Santos VP, 2013, REV ASSOC MED BRAS, V59, P557, DOI [10.1016/j.ramb.2013.06.009, 10.1590/S0104-42302013000600008]
  20. Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714
  21. Gary T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067688
  22. Gibson PH, 2007, AM HEART J, V154, P995, DOI 10.1016/j.ahj.2007.06.043
  23. Giugliano G, 2010, ATHEROSCLEROSIS, V210, P288, DOI 10.1016/j.atherosclerosis.2009.11.009
  24. Hamirani YS, 2008, ATHEROSCLEROSIS, V201, P1, DOI 10.1016/j.atherosclerosis.2008.04.045
  25. Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054
  26. IIJIMA R, 2002, THROMBOSIS AND HAEMO, V98, P852, DOI 10.1160/TH07-04-0285
  27. Ikeoka D, 2010, REV ASSOC MED BRAS, V56, P116, DOI 10.1590/S0104-42302010000100026
  28. Jenny NS, 2010, ATHEROSCLEROSIS, V209, P226, DOI 10.1016/j.atherosclerosis.2009.08.037
  29. Jung DH, 2011, PLATELETS, V22, P567, DOI 10.3109/09537104.2011.580397
  30. Kalay N, 2012, ANGIOLOGY, V63, P213, DOI 10.1177/0003319711412763
  31. Kirtane AJ, 2004, AM J CARDIOL, V93, P532, DOI 10.1016/j.amjcard.2003.11.013
  32. Koenig W, 2013, INT J CARDIOL, V168, P5126, DOI 10.1016/j.ijcard.2013.07.113
  33. Li H, 2017, KARDIOL POL, V75, P665, DOI 10.5603/KP.a2017.0068
  34. Li JJ, 2007, AGEING RES REV, V6, P263, DOI 10.1016/j.arr.2007.09.001
  35. Libby P, 2015, CIRC RES, V116, P307, DOI 10.1161/CIRCRESAHA.116.301313
  36. Liberman M, 2013, EINSTEIN-SAO PAULO, V11, P376, DOI 10.1590/S1679-45082013000300021
  37. Lubrano Valter, 2015, World J Exp Med, V5, P21, DOI 10.5493/wjem.v5.i1.21
  38. Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056
  39. Moye L, 2016, CIRC RES, V118, P439, DOI 10.1161/CIRCRESAHA.115.306305
  40. Nam SH, 2017, BIOMED RES INT, DOI 10.1155/2017/1989417
  41. Papa A, 2008, CLIN CHIM ACTA, V395, P27, DOI 10.1016/j.cca.2008.04.019
  42. Raaz-Schrauder D, 2012, CYTOKINE, V57, P251, DOI 10.1016/j.cyto.2011.11.015
  43. Rana JS, 2007, J INTERN MED, V262, P678, DOI 10.1111/j.1365-2796.2007.01864.x
  44. Serrano CV, 2011, VASC HEALTH RISK MAN, V7, P143, DOI 10.2147/VHRM.S16328
  45. Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005
  46. Taylor AJ, 2010, AM J CARDIOL, V106, P47, DOI 10.1016/j.amjcard.2010.02.009
  47. THOMSON SP, 1995, ANN INTERN MED, V122, P335, DOI 10.7326/0003-4819-122-5-199503010-00003
  48. Unlu M, 2015, CARDIOLOGY, V133, P56, DOI 10.1159/000438981
  49. Verdoia M, 2016, ANGIOLOGY, V67, P75, DOI 10.1177/0003319715577529
  50. Wang XD, 2014, ATHEROSCLEROSIS, V234, P206, DOI 10.1016/j.atherosclerosis.2014.03.003
  51. Weymann A, 2018, KARDIOL POL, V76, P107, DOI 10.5603/KP.a2017.0179
  52. Weymann A, 2017, MED SCI MONIT BASIC, V23, P179, DOI 10.12659/MSMBR.903320
  53. Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624
  54. Zakynthinos E, 2009, J CARDIOL, V53, P317, DOI 10.1016/j.jjcc.2008.12.007
  55. Zouridakis EG, 2000, AM J CARDIOL, V86, P449, DOI 10.1016/S0002-9149(00)00963-2

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - LIM/65
Artigos e Materiais de Revistas Científicas - ODS/03